The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...
The Punch on MSN2d
Groundbreaking sickle cell disease treatment approved for English NHSSickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as haemoglobin S. Sickle cell disease changes the shape of blood cells into a crescent ...
WBRE Wilkes-Barre on MSN2d
Deer disease seen for first time in Luzerne CountyA fatal neurological disease is hitting NEPA wildlife. Two separate cases of Chronic Wasting Disease (CWD) have been ...
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...
The spleen is a vital part of your immune system, located on the left side of your body beneath the rib cage. Various conditions or diseases can lead to an enlarged spleen. If it isn’t treated ...
In the most remote places in the world, people are daily battling diseases that many people may never have heard of. Called neglected tropical diseases, the World Health Organization (WHO) officially ...
and an enlarged spleen, but do not slow progression of the disease or reduce the risk of it evolving into acute leukemia. In theory, using RSK1 inhibitors to treat patients with chronic MPNs may ...
ABSTRACT: Introduction: The association of sickle cell disease and pregnancy is a risky situation for the mother as well as the fetus and even the neonate. The objective of this work was to study the ...
Organ weights may help determine if there’s an abnormality and help with diagnosis. Some diseases are related to organ size changes, such as an enlarged heart, spleen, or prostate gland. Looking ...
2023 — Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib ...
which includes components of your immune system such as your lymph nodes and spleen. About one in 50 people—or 2 percent—will develop non-Hodgkin lymphoma during their lifetimes. It's not clear ...
The FDA has offered positive feedback on possible paths forward for accelerated or traditional approval of FLT201 using data from a single-arm study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback